Sign in

Triple-negative breast cancer trials, also abroad

477 open Triple-negative breast cancer trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

CountryOpen trials
United States172
China133
France43
Spain33
Australia31
Italy31
Germany27
United Kingdom26
Canada23
Japan23
South Korea23
Belgium16
Israel12
Netherlands12
Poland10
Singapore9
Brazil8
Portugal8
Taiwan8
Argentina6
Colombia6
India6
Mexico6
Austria5
Switzerland5
Greece5
Türkiye5
Chile4
Czechia4
Hong Kong4
Ireland4
Romania4
Sweden4
South Africa4
Finland3
Malaysia3
New Zealand3
Philippines3
Puerto Rico3
Thailand3
Vietnam3
Georgia2
Hungary2
Indonesia2
Nigeria2
Norway2
Peru2
Saudi Arabia2
Ukraine2
United Arab Emirates1
Barbados1
Belarus1
Ghana1
Guatemala1
Jamaica1
Russia1
Slovenia1

The same trial often runs in several countries

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011) has 4 sites in Denmark and runs in 35 countries. If a site near you is full, another one may still take people.

See A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011) in all 35 countries
Triple-negative breast cancer trials in Denmark – Frontlight Research